NCT06597487

Brief Summary

This study aims to evaluate the effect of prognostic factors, such as the degree of pulpal inflammation and the radiographic caries depth, on the success of full pulpotomy in mature permanent molars with irreversible pulpitis.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
58

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Oct 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 11, 2024

Completed
8 days until next milestone

First Posted

Study publicly available on registry

September 19, 2024

Completed
26 days until next milestone

Study Start

First participant enrolled

October 15, 2024

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2025

Completed
Last Updated

July 25, 2025

Status Verified

July 1, 2025

Enrollment Period

9 months

First QC Date

September 11, 2024

Last Update Submit

July 22, 2025

Conditions

Keywords

irreversible pulpitisfull pulpotomyartificial intelligence

Outcome Measures

Primary Outcomes (2)

  • Percentage of Successful Cases

    * It will be measured as a percentage. * It will be decided according to the clinical and radiographic criteria of success and failure.

    After 1, 3, and 6 months

  • Diagnostic accuracy (Sensitivity and Specificity) of an artificial intelligence software in detecting carious pulp exposure

    * The Artificial Intelligence (AI) software will process pre-operative radiographs to predict the presence of carious pulp exposure. The AI findings will be compared to the clinical findings of carious pulp exposure after caries removal. (Clinical finding of carious pulp exposure will be used as the gold standard). * The outcome will be reported as Sensitivity and Specificity.

    On the day of the procedure

Study Arms (2)

Root Canal Treatment

ACTIVE COMPARATOR

The patients allocated to this arm will receive conventional root canal treatment. They will be followed up for 1, 3 and 6 months to assess clinical and radiographic success.

Procedure: Conventional root canal treatment

Full Pulpotomy

EXPERIMENTAL

The patients allocated to this arm will receive full pulpotomy. They will be followed up for 1, 3 and 6 months to assess clinical and radiographic success.

Procedure: Full pulpotomy

Interventions

The patients will receive full pulpotomy as follows: -Under rubber dam isolation, the operator will perform caries removal, complete the access cavity preparation, achieve hemostasis from all canals, and apply the bioceramic material. The operator will seal the cavity with glass ionomer restoration.

Full Pulpotomy

The patients will receive conventional root canal treatment, which is the gold standard treatment protocol in cases with irreversible pulpitis.

Root Canal Treatment

Eligibility Criteria

Age20 Years - 45 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Mature permanent molars with irreversible pulpitis.
  • Presence of bleeding pulp tissues from all canals.
  • The tooth is not periodontally compromised.

You may not qualify if:

  • Non-vital teeth.
  • Uncontrolled bleeding from any of the canals after ten minutes of application of hemostatic agent.
  • Molars with immature roots.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Misr International University

Cairo, Egypt

Location

Study Officials

  • Ahmed A Ghobashy, Prof. Dr.

    Misr International University

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

September 11, 2024

First Posted

September 19, 2024

Study Start

October 15, 2024

Primary Completion

July 1, 2025

Study Completion

July 1, 2025

Last Updated

July 25, 2025

Record last verified: 2025-07

Locations